Patheon has opened a new Pharmaceutical Development Services (PDS) suite at its Whitby Development Center in Canada for the small-scale development and manufacturing of solid dosage forms for early clinical studies.     The 2,500-sq.-ft. suite, as well as the facility, are GMP-compliant for manufacturing products for Phase I and II clinical studies. The suite will contribute to Patheon’s Quick To Clinic offering for First Time in Human (Phase I) studies. The new facility will also add e...